George Braun, MD
Plastic Surgery within the Head & Neck · New York, NYNPI 1235292855
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Optinose US, Inc. accounts for 77.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $3,220 and has fallen 95.2% since, to $154 in 2025.
Across 54 payments — averaging $79.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$3K
- GSK$362
- Sanofi$341
- Regeneron Healthcare Solutions, Inc.$236
- Hikma Pharmaceuticals USA$18
What the payments were for
- Consulting fees$2,50059%
- Travel & lodging$45111%
- Food & beverage$1,32031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 14 | $3,314 |
| GSK | 16 | $362 |
| Sanofi | 13 | $341 |
| Regeneron Healthcare Solutions, Inc. | 10 | $236 |
| Hikma Pharmaceuticals USA | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,271 in reported general payments places this provider in the 80th percentile of 45 plastic surgery within the head & neck providers in New York.
See all plastic surgery within the head & neck providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 784 | $13,394 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 123 | $12,393 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 96 | $4,261 |
| Mometasone Furoate | 94 | $3,161 |
| Desloratadine | 37 | $1,487 |
| Cefdinir | 105 | $1,351 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 30 | $1,291 |
| Meclizine Hcl | 73 | $704 |
| Triamcinolone Acetonide | 25 | $659 |
| Montelukast Sodium | 55 | $591 |
| Methylprednisolone | 48 | $289 |
| Fluticasone Propionate | 32 | $282 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $277 |
| Fluconazole | 12 | $275 |
| Nystatin | 16 | $218 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in New York
- Robert SchwarczNew York$188K
- Eric CohenNew York$9K
- Erich VoigtNew York$6K
- Adrian OngNew York$3K
- Thomas RomoNew York$3K
- Solomon HusainNew York$3K
- Guy LinNew York$2K
- Abraham ZimmNew York$1K
- Wojciech DecNew York$1K
- David EdelsteinNew York$773
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.